Vanderbilt University Buys Shares of 88,482 Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Vanderbilt University bought a new stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 88,482 shares of the real estate investment trust's stock, valued at approximately $1,647,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. State of Alaska Department of Revenue boosted its holdings in Sabra Health Care REIT by 0.6% in the first quarter. State of Alaska Department of Revenue now owns 135,087 shares of the real estate investment trust's stock valued at $1,993,000 after acquiring an additional 755 shares during the last quarter. Retirement Systems of Alabama raised its position in Sabra Health Care REIT by 0.3% in the first quarter. Retirement Systems of Alabama now owns 290,353 shares of the real estate investment trust's stock valued at $4,289,000 after purchasing an additional 761 shares during the period. Commonwealth Equity Services LLC raised its position in Sabra Health Care REIT by 1.4% in the first quarter. Commonwealth Equity Services LLC now owns 64,952 shares of the real estate investment trust's stock valued at $959,000 after purchasing an additional 928 shares during the period. GAMMA Investing LLC raised its position in Sabra Health Care REIT by 25.3% in the third quarter. GAMMA Investing LLC now owns 4,614 shares of the real estate investment trust's stock valued at $86,000 after purchasing an additional 932 shares during the period. Finally, Mercer Global Advisors Inc. ADV raised its position in Sabra Health Care REIT by 2.5% in the second quarter. Mercer Global Advisors Inc. ADV now owns 48,448 shares of the real estate investment trust's stock valued at $746,000 after purchasing an additional 1,168 shares during the period. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Health Care REIT Stock Up 1.4 %

Sabra Health Care REIT stock traded up $0.27 during midday trading on Monday, hitting $19.07. The stock had a trading volume of 2,002,796 shares, compared to its average volume of 2,018,050. The company has a current ratio of 4.27, a quick ratio of 4.27 and a debt-to-equity ratio of 0.89. The stock has a market cap of $4.41 billion, a P/E ratio of 95.35, a P/E/G ratio of 2.69 and a beta of 1.26. Sabra Health Care REIT, Inc. has a 12 month low of $12.83 and a 12 month high of $19.32. The business has a fifty day moving average price of $17.98 and a 200 day moving average price of $16.05.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.24). The firm had revenue of $176.14 million during the quarter, compared to the consensus estimate of $166.54 million. Sabra Health Care REIT had a net margin of 7.83% and a return on equity of 1.87%. The firm's quarterly revenue was up 9.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.34 earnings per share. Research analysts predict that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 19th were paid a $0.30 dividend. The ex-dividend date of this dividend was Monday, August 19th. This represents a $1.20 dividend on an annualized basis and a yield of 6.29%. Sabra Health Care REIT's payout ratio is currently 600.00%.

Analyst Ratings Changes

Several research analysts have commented on SBRA shares. Truist Financial raised their price objective on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Scotiabank raised their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a "sector perform" rating in a research report on Friday, October 11th. Citigroup raised Sabra Health Care REIT from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $17.00 to $20.00 in a research report on Friday, September 13th. Finally, Wells Fargo & Company raised Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $16.00 to $20.00 in a research report on Tuesday, October 1st. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $18.38.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.